Cmarr/miR-540-3p axis promotes cardiomyocyte maturation transition by orchestrating Dtna expression

The immature phenotype of embryonic stem cell-derived cardiomyocytes (ESC-CMs) limits their application. However, the molecular mechanisms of cardiomyocyte maturation remain largely unexplored. This study found that overexpression of long noncoding RNA (lncRNA)-Cmarr, which was highly expressed in c...

Full description

Saved in:
Bibliographic Details
Published in:Molecular therapy. Nucleic acids 2022-09, Vol.29, p.481-497
Main Authors: Wu, Yukang, Guo, Xudong, Han, Tong, Feng, Ke, Zhang, Peng, Xu, Yanxin, Yang, Yiwei, Xia, Yuchen, Chen, Yang, Xi, Jiajie, Yang, Huangtian, Wan, Xiaoping, Kang, Jiuhong
Format: Article
Language:English
Subjects:
cardiac patch
cardiomyocyte maturation
Cmarr
DGC
Dtna
miR-540-3p
MT:Noncoding RNAs
myocardial infarction
Original
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The immature phenotype of embryonic stem cell-derived cardiomyocytes (ESC-CMs) limits their application. However, the molecular mechanisms of cardiomyocyte maturation remain largely unexplored. This study found that overexpression of long noncoding RNA (lncRNA)-Cmarr, which was highly expressed in cardiomyocytes, promoted the maturation change and physiological maturation of mouse ESC-CMs (mESC-CMs). Moreover, transplantation of cardiac patch overexpressing Cmarr exhibited better retention of mESC-CMs, reduced infarct area by enhancing vascular density in the host heart, and improved cardiac function in mice after myocardial infarction. Mechanism studies identified that Cmarr acted as a competitive endogenous RNA to impede the repression of miR-540-3p on Dtna expression and promoted the binding of the dystrophin-glycoprotein complex (DGC) and yes-associated protein (YAP), which in turn reduced the proportion of nuclear YAP and the expression of YAP target genes. Therefore, this study revealed the function and mechanism of Cmarr in promoting cardiomyocyte maturation and provided a lncRNA that can be used as a functional factor in the construction of cardiac patches for the treatment of myocardial infarction. [Display omitted] Kang and colleagues described that lncRNA Cmarr competed with miR-540-3p and released its inhibition on Dtna expression, facilitating the DGC-YAP complex formation and promoting the maturation of mESC-CMs. They also showed that the Cmarr-engineered patch recovered the impaired function of MI heart and provided a functional lncRNA in cardiomyocyte maturation and MI treatment.
ISSN:2162-2531
2162-2531
DOI:10.1016/j.omtn.2022.07.022